Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Monsanto Roundup Cancer Trial Postponed in St. Louis, Bayer Stock Climbs

Health + Wellness
The compound of German chemicals and pharmaceuticals giant Bayer in Berlin on March 20, 2019. ODD ANDERSEN / AFP via Getty Images

By Carey Gillam

A highly anticipated Roundup cancer trial set to start later this month in the St. Louis area has been pulled from the docket, a court official said on Wednesday.


The trial, which was to pit a woman named Sharlean Gordon against Roundup maker Monsanto Co., was to start Jan. 27 in St. Louis County and was to be broadcast to the public. Notably, Gordon's lawyers planned to put former Monsanto CEO Hugh Grant on the stand. St. Louis was the home of Monsanto's corporate headquarters until the company was purchased by Bayer AG of Germany in June of 2018.

In taking the trial off the calendar, the judge in the case has ordered that a status conference be set for a month from now, said St. Louis County Court spokeswoman Christine Bertelson.

The Gordon trial was already postponed once – it originally was scheduled for August. It is one of several trials that have been postponed in the last several months as Bayer attempts to find a settlement to the mass of claims filed against Monsanto by people stricken with non-Hodgkin lymphoma they claim was caused by exposure to Monsanto Roundup and other glyphosate-based herbicides. Bayer officials have said that Monsanto is facing more than 42,700 plaintiffs in the U.S.

Gordon developed non-Hodgkin lymphoma after using Roundup herbicides for 25 years at her residence in South Pekin, Illinois, and has suffered extensive debilitation due to her disease. Gordon's stepfather, who also used Roundup at the family home, died of cancer. The case is actually derived from a larger case filed in July 2017 on behalf of more than 75 plaintiffs. Gordon was to be the first of that group to go to trial.

Monsanto and Bayer have denied that Monsanto's herbicides can cause cancer, and assert the litigation is without merit but is being fueled by greedy plaintiffs' attorneys.

According to sources close to the litigation, discussions are underway to postpone more Roundup cancer trials, possibly including one set to start Jan. 21 in St. Louis City Court. Attorneys for Monsanto and for the plaintiffs in the upcoming January trials declined to comment.

Shares in Bayer hit a 52-week high and were up close to 3 percent Wednesday. Investors have been pushing the company to find a way to avoid future trials and to settle the litigation.

In the three Roundup cancer trials held so far, unanimous juries have found that exposure to Monsanto's herbicides does cause non-Hodgkin lymphoma and that the company covered up the risks and failed to warn consumers. The three juries awarded a total of four plaintiffs more than $2 billion in damages, but the trial judges in each case have reduced the awards significantly.

No damages have yet been paid as Monsanto appeals the verdicts.

Bayer's annual shareholders' meeting is set for April 28 and analysts said investors would like to see either a settlement of the litigation by that time, or at least meaningful progress in containing the liability. Bayer's stock took a dive, losing billions of dollars in value, after the first jury verdict in August 2018, and share prices remain depressed.

Reposted with permission from U.S. Right to Know.

EcoWatch Daily Newsletter

A bald eagle chick inside a nest in Rutland, Massachusetts. Massachusetts Division of Fisheries and Wildlife
A bald eagle nest with eggs has been discovered in Cape Cod for the first time in 115 years, according to the Massachusetts Division of Fisheries and Wildlife (Mass Wildlife), as Newsweek reported.
Read More Show Less
The office of Rover.com sits empty with employees working from home due to the coronavirus pandemic on March 12 in Seattle, Washington. John Moore / Getty Images

The office may never look the same again. And the investment it will take to protect employees may force many companies to go completely remote. That's after the Centers for Disease Control and Prevention (CDC) issued new recommendations for how workers can return to the office safely.

Read More Show Less
Frederic Edwin Church's The Icebergs reveal their danger as a crush vessel is in the foreground of an iceberg strewn sea, 1860. Buyenlarge / Getty Images

Scientists and art historians are studying art for signs of climate change and to better understand the ways Western culture's relationship to nature has been altered by it, according to the BBC.

Read More Show Less
Esben Østergaard, co-founder of Lifeline Robotics and Universal Robots, takes a swab in the World's First Automatic Swab Robot, developed with Thiusius Rajeeth Savarimuthu, professor at the Maersk Mc-Kinney Moller Institute at The University of Southern Denmark. The University of Southern Denmark

By Richard Connor

The University of Southern Denmark on Wednesday announced that its researchers have developed the world's first fully automatic robot capable of carrying out throat swabs for COVID-19.

Read More Show Less
Jackson Family Wines in California discovered that a huge amount of carbon pollution was caused by manufacturing wine bottles. Edsel Querini / Getty Images

Before you pour a glass of wine, feel the weight of the bottle in your hand. Would you notice if it were a few ounces lighter? Jackson Family Wines is betting that you won't.

Read More Show Less
The SpaceX crew capsule will launch out of Cape Canaveral, Florida. SpaceX

After a minor setback, a new era in space travel and tourism is set to launch this weekend.

Read More Show Less

Trending

A former Federal Reserve board of governors member on Thursday called on her former colleagues to stop using Covid-19 relief funds to bail out the "dying" fossil fuel industry. Douglas Sacha / Getty Images

By Eoin Higgins

A former Federal Reserve board of governors member on Thursday called on her former colleagues to stop using Covid-19 relief funds to bail out the "dying" fossil fuel industry, calling the decision a threat to the planet's climate and a misguided use of taxpayer money.

Read More Show Less